PAR 2.13% 23.0¢ paradigm biopharmaceuticals limited..

Action, page-3

  1. 238 Posts.
    lightbulb Created with Sketch. 20
    Has gotten very quite. Volume is low and the price dribbles near but under the 1$. Does anyone know if the current shutdown in the US could have an impact on FDA approvals, fast tracked or not?
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.